Showing 17 articles tagged
'Advanced prostate cancer':

Research centre attracts royal interest as groundbreaking trials continue to deliver

22 Sep 2017

The Duchess of Gloucester met with researchers and clinical triallists on a royal visit to our Belfast-Manchester Movember Centre of Excellence, where attempts to find new ways to tackle advanced prostate cancer are already showing exciting early results.

If you’re confronting death because of prostate cancer, we’re here for you

8 May 2017

While most men survive prostate cancer, one man every hour dies from the disease. As Dying Matters Awareness Week begins, we join together with men confronting advanced prostate cancer to help everyone talk about the ultimate taboo and highlight the support on offer.

Scientists find greater link between men with advanced prostate cancer and inherited gene mutations

7 Jul 2016

Research published today has discovered a far higher proportion of inherited DNA mutations in men with advanced prostate cancer than previously suspected, opening up new possibilities for targeted treatments.

New support for men and their loved ones who are confronting death

9 May 2016

To coincide with Dying Matters Week, we've launched a new section of our website full of practical tips and personal stories to help men with advanced prostate cancer - and the people closest to them - to prepare for the end of their life.

Walk of love: one man's determination to step out with his wife on Valentine's Day

12 Feb 2016

Why a walk to a local restaurant for a romantic meal was such a special moment for one couple dealing with prostate cancer.

Kurt Jewson: the selfless selfie that raised mass awareness of prostate cancer

3 Feb 2016

With the overwhelming public response to Kurt Jewson's Facebook photo following prostate cancer treatment, we explain the rarity of the disease in men under 50 and why the symptoms are so difficult to spot.

NICE decision on enzalutamide and abiraterone without chemo a mixed result

11 Dec 2015

After more than a year of back and forth between NICE and drugs manufacturers, a decision about routine access to two advanced prostate cancer drugs, abiraterone and enzalutamide, without prior chemotherapy is finally in sight.

A year of Excellence for our new research centres

23 Nov 2015

It's almost a year since our Movember Centres of Excellence opened their doors for business. Here’s a roundup of what's happened so far.

Blood test can measure abiraterone's effectiveness, new trial reveals

4 Nov 2015

Researchers find DNA in blood samples can determine when life-prolonging drug abiraterone has stopped working in men with advanced prostate cancer.

NICE set to say no to enzalutamide without chemotherapy

11 Jun 2015

It’s not been a good week for men. Hot on the heels of two other disappointing decisions), NICE (the National Institute of Health and Care Excellence) has just announced their intention not to make enzalutamide routinely available to men with advanced prostate cancer who haven’t had chemotherapy.